4D Molecular Therapeutics
FDMT
#7583
Rank
NZ$0.51 B
Marketcap
$11.15
Share price
9.17%
Change (1 day)
-66.08%
Change (1 year)

4D Molecular Therapeutics (FDMT) - Net assets

Net assets on the balance sheet as of September 2024 : NZ$0.97 Billion

According to 4D Molecular Therapeutics's latest financial reports the company has NZ$0.97 Billion in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

4D Molecular Therapeutics - Net assets on balance sheet (from 2018 to 2024)

Net assets by year

Year Net assets Change
2023-12-31$NZ$0.48 B33.59%
2022-12-31$NZ$0.36 B-22.01%
2021-12-31$NZ$0.46 B31.48%
2020-12-31$NZ$0.35 B-427.96%
2019-12-31$-NZ$0.11 Billion163.45%
2018-12-31$-NZ$41.13 Million49.1%
2017-12-31$-NZ$27.59 Million

Net assets for similar companies or competitors

Company Net assets differencediff. Country
NZ$0.48 B-50.45%๐Ÿ‡บ๐Ÿ‡ธ USA